Evaluation of transformation growth factor β1, interleukin-10, and interferon-γ in male symptomatic and asymptomatic dogs naturally infected by Leishmania (Leishmania) chagasi

Veterinary Parasitology

Volumn 143, Issue 3-4, 2007, Pages 267-274

  Corrêa, Ana Paula Ferreira Lopes ^a   Dossi, Ana Cláudia Silva ^a   de Oliveira Vasconcelos, Rosemeri ^a   Munari, Danísio Prado ^a   de Lima, Valéria Marçal Felix ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Cytokines; ELISA; Spleen cell culture; Th2 response; Visceral leishmaniasis; Zoonosis

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; BRAZIL; CACHEXIA; CLINICAL FEATURE; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION; IMMUNOMODULATION; LEISHMANIA CHAGASI; LEISHMANIASIS; LOCOMOTION; NONHUMAN; SPLEEN CELL;

ANIMALS; DOG DISEASES; DOGS; INTERFERON TYPE II; INTERLEUKIN-10; LEISHMANIA; LEISHMANIASIS, VISCERAL; LIVER; MALE; SPLEEN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMALIA; CANIS FAMILIARIS; LEISHMANIA DONOVANI CHAGASI; LEISHMANIA SP.;

EID: 33846356709     PISSN: 03044017     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetpar.2006.08.023     Document Type: Article

References (40)

1. Abranches P., Silva-Pereira M.C., Conceição-Silva F.M., Santos-Gomes G.M., and Janz J.G. Canine leishmaniasis: pathological and ecological factors influencing transmission of infection. J. Parasitol. 77 (1991) 557-561
2. Alencar J.E., Neves J., and Dietze R. Leishmaniose visceral (Calazar). In: Veronezi R. (Ed). Doenças Infecciosas e Parasitárias. eighth ed. (1991), Guanabara Koogan, Rio de Janeiro 706-717
3. Ansari N.A., Saluja S., and Salotra P. Elevated levels of interferon-gamma, interleukin-10, and interleukin-6 during active disease in Indian kala azar. Clin. Immunol. 119 (2006) 339-345
4. Bacellar O., D'Oliveira Jr. A., Jerônimo S., and Carvalho E.M. IL-10 and IL-12 are the main regulatory cytokines in visceral leishmaniasis. Cytokine 12 (2000) 1228-1231
5. Barral A., Barral-Netto M., Yong E.C., Brownell C.E., Twardzik D.R., and Reed S.G. Transforming growth factor β as a virulence mechanism for Leishmania braziliensis. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 3442-3446
6. Barral-Netto M., Barral A., Brownell C.E., Skeiky Y.A.W., Ellingsworth L.R., Twardzik D.R., and Reed S.G. Transforming growth factor-b in leishmanial infection: a parasite escape mechanism. Science 257 (1992) 545-548
7. Bogdan C., Vodovotz Y., and Nathan C. Macrophage deactivation by interleukin 10. J. Exp. Med. 174 (1991) 1549-1555
8. Bright J.J., and Sriram S. TGF-b inhibits IL-12-induced activation of Jak-STAT pathway in T lymphocytes. J. Immunol. 161 (1998) 1772-1777
9. Chamizo C., Moreno J., and Alvar J. Semi-quantitative analysis of cytokine expression in asymptomatic canine leishmaniasis. Vet. Immunol. Immunopathol. 103 (2005) 67-75
10. Cher D.J., and Mosmann T.R. Two types of murine helper cell clone. II Delayed-type hypersensitivity is mediated by Th1 clones. J. Immunol. 138 (1987) 3688-3694
11. Coffman R.L., Seymour B.W., Lebman D.A., Hiraki D.D., Christiansen J.A., Shader B., Cherwinski H.M., Savelkoul H.F., Finkelman F.D., and Bond M.W. The role of helper T cell products in mouse B cell differentiation and isotype regulation. Immunol. Rev. 102 (1988) 5-28
12. Costa C.H., and Vieira J.B. Changes in the control program of visceral leishmaniasis in Brazil. Rev. Soc. Bras. Med. Trop. 34 (2001) 223-228
13. Dasgupta B., Roychoudhury K., Ganguly S., Kumar Sinha P., Vimal S., Das P., and Roy S. Antileishmanial drugs cause up-regulation of interferon-gamma receptor 1, not only in the monocytes of visceral leishmaniasis cases but also in cultured THP1 cells. Ann. Trop. Med. Parasitol. 97 (2003) 245-257
14. Enserink M. Infectious diseases. Has leishmaniasis become endemic in the US?. Science 290 (2000) 1881-1883
15. Gasim S., Elhassan A.M., Khalil E.A., Ismail A., Kadaru A.M., Kharazmi A., and Theander T.G. High levels of plasma IL-10 and expression of IL-10 by keratinocytes during visceral leishmaniasis predict subsequent development of post-kala-azar dermal leishmaniasis. Clin. Exp. Immunol. 112 (1998) 547
16. Ghalib H.W., Piuvezam M.R., Skeiky Y.A., Siddig M., Hashim F.A., el-Hassan A.M., Russo D.M., and Reed S.G. Interleukin 10 production correlates with pathology in human Leishmania donovani infections. J. Clin. Invest. 92 (1993) 324-329
17. Herwaldt B.L. Leishmaniasis. Lancet 354 (1999) 1191-1199
18. Holzmuller P., Cavaleyra M., Moreaux J., Kovacic R., Vincendeau P., Papierok G., and Lemesre J.-L. Lymphocytes of dog immunized with purified excreted-secreted antigens of Leishmania infantum co-incubated with Leishmania infected macrophages produce INF gamma resulting in nitric oxide-mediated amastigote apoptosis. Vet. Immunol. Immunopathol. 106 (2005) 247-257
19. Howard M., and O'Garra A. Biological properties of interleukin 10. Immunol. Today 13 (1992) 198-200
20. Karp C.L., El-Safi S.H., Wynn T.A., Satti M.M.H., Kordofani A.M., Hashim F.A., Hag-Ali M., Neva F.A., Nutman T.B., and Sacks D.L. In vivo cytokine profiles in patients with kala-zar: marked elevation of both interleukin-10 and interferon-gamma. J. Clin. Invest. 91 (1993) 1644-1648
21. Kehrl J.H., Roberts A.B., Wakefield L.M., Jakowlew S., Sporn M.B., and Fauci A.S. Transforming growth factor beta is an important immunomodulatory protein for human B lymphocytes. J. Immunol. 12 (1986) 3855-3860
22. Lima V.M.F., Gonçalves M.E., Ikeda F.A., Luvizotto M.C.R., and Feitosa M.M. Anti-leishmania antibodies in cerebrospinal fluid from dogs with visceral leishmaniasis. Braz. J. Med. Biol. Res. 36 (2003) 485-489
23. Mosmann T.R., Cherwinski H., Bond M.W., Giedlin M.A., and Coffman R.L. Two types of murine helper T cell clone. I. Definition according to profiles the lymphokines activities and secreted proteins. J. Immunol. 136 (1986) 2348-2357
24. Murray H.W., Squire K.E., Miralles C.D., Stoeckle M.Y., Granger A.M., Granelli-Piperno A., and Bogdan C. Acquired resistance and granuloma formation in experimental visceral leishmaniasis. J. Immunol. 148 (1992) 1858
25. Murray H.W., Haripraaashad J., Aguero B., Arakawa T., and Yeganegi H. Antimicrobial response of a T cell deficient host to cytokine therapy: effect of interferon-γ in experimental Visceral Leishmaniasis in nude mice. J. Infect. Dis. 171 (1995) 1309-1316
26. Murray H.W., Lu C.M., Mauze S., Freeman S., Moreira A.L., Kaplan G., and Coffman R.L. Interleukin-10 (IL-10) in experimental visceral leishmaniasis and IL-10 receptor blockade as immunotherapy. Infect. Immun. 70 (2002) 6284-6293
27. Paranhos M., dos Santos W.C., Sherlock I., Oliveira G.G., and de Carvalho L.C. Development of eosinophilia in dogs intradermically inoculated with sand fly saliva and Leishmania (Leishmania) chagasi stationary-phase promastigotes. Mem. Inst. Oswaldo Cruz 88 (1993) 249-251
28. Paranhos-Silva M., Freitas L.A., Santos W.C., Grimaldi Jr. G., Pontes-de-Carvalho L.C., and Oliveira-dos-Santos A.J. A cross-sectional serodiagnostic survey of canine leishmaniasis due to Leishmania chagasi. Am. J. Trop. Med. Hyg. 55 (1996) 39-44
29. Pearson R.D., and Sousa A.Q. Clinical spectrum of leishmaniasis. Clin. Infect. Dis. 22 (1996) 1-13
30. Quinnell R.J., Courtenay O., Shaw M.A., Day M.J., Garcez L.M., Dye C., and Kaye P.M. Tissue cytokine responses in canine visceral leishmaniasis. J. Infect. Dis. 183 (2001) 1421-1424
31. Reiner S.L., and Locksley R.M. The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 13 (1995) 151-177
32. RodriguesFV. Jr., Silva J.S., and Campos-Neto A. Transforming growth factor β and immunosupression in experimental visceral leishmaniasis. Infect. Immun. 66 (1998) 1233-1236
33. Santos-Gomes G.M., Rosa R., Leandro C., Cortes S., Romao P., and Silveira H. Cytokine expression during the outcome of canine experimental infection by Leishmania infantum. Vet. Immunol. Immunopathol. 88 (2002) 21-30
34. Silva E.S., Gontijo C.M., Pacheco R.S., Fiúza V.O., and Brazil R.P. Visceral leishmaniasis in Metropolitan region of Belo Horizonte, State of Minas Gerais, Brazil. Mem. Inst. Oswaldo Cruz 96 (2001) 285-291
35. Slappendel R.J., and Ferrer L. Leishmaniasis. In: Greene C.E. (Ed). Clinical Microbiology and Infectious Diseases of the Dog and Cat (1990), W.B. Saunders Co., Philadelphia 450-458
36. Trichieri G., Rengaraju M., D'Andrea A., Valiante N.M., Kubin M., Aste M., and Chehimi J. Producer cells of interleukin-12. Immunol. Today 14 (1993) 237-238
37. Vercelli A., Bellone G., Abate O., Emanuelli G., and Cagnasso A. Expression of transforming growth factor β isoforms in the skin, kidney, pancreas and bladder in german shepherd dog affected by renal cystadenocarcinoma and nodular dermatofibrosis. J. Vet. Med. 50 (2003) 506-510
38. Walh S.M. Transforming growth factor beta: the good, the bad, and the ugly. J. Exp. Med. 180 (1994) 1587-1590
39. Walker P.S., Scharton-Kersten T., Krieg A.M., Love-Homan L., Rowton E.D., Udey M.C., and Vogel J.C. Immunoestimulatory oligodeoxynucleotides promote protective immunity and provide systemic therapy for leishmaniasis via IL-12 and IFN-γ dependent mechanisms. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 6970-6975
40. Wilson M.E., Young B.M., Davidson B.L., Mente K.A., and McGowan S.E. The importance of transforming growth factor β in murine visceral leishmaniasis. J. Immunol. 161 (1998) 6148-6155